Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Nitric Oxide Signaling Pathway

Nitric Oxide Signaling Pathway

Nitric oxide (NO), an inorganic gas, acts as a potent second messenger in most animal and plant tissues. NO diffuses out of the cells that produce it and enters the neighboring cells to generate a downstream response. NO synthase (NOS) catalyzes NO production by the deamination of the amino acid arginine. There are three isoforms of NOS. Endothelial cells have endothelial NOS (eNOS), nerve and muscle cells have neuronal NOS (nNOS), and macrophages produce inducible NOS (iNOS) upon exposure to...

Feedback Inhibition

Feedback Inhibition

Biochemical reactions are occurring constantly in cells, converting starting substances to different products, usually with the help of enzymes that speed the reactions. Without enzymes, it would take far too long for most reactions to occur to be useful to the cell!

Antihypertensive Drugs: Vasodilators

Antihypertensive Drugs: Vasodilators

Vasodilators, primarily affecting the smooth muscles within arterial and venous walls, are commonly used for hypertension treatment. Medications such as minoxidil and hydralazine primarily target arteries and arterioles, while sodium nitroprusside acts on arterioles and venules. Minoxidil, functioning as a prodrug, is metabolized by hepatic sulfotransferase into its active form, minoxidil sulfate, after oral administration. This metabolite binds to the sulfonylurea receptor (SUR) component of...

Enzyme Inhibition

Enzyme Inhibition

Inhibitors are molecules that reduce enzyme activity by binding to the enzyme. In a normally functioning cell, enzymes are regulated by a variety of inhibitors. Drugs and other toxins can also inhibit enzymes. Some inhibitors bind to the enzyme’s active site, while others inhibit enzymatic activity by binding to other sites on the protein structure.

Eukaryotic Transcription Inhibitors

Eukaryotic Transcription Inhibitors

Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a DNA...

Inhibitors of Viral Protein Synthesis

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Influence of a novel inhibitor (UM8190) of prolylcarboxypeptidase (PRCP) on appetite and thrombosis.

Current medicinal chemistry·2012

Same author

Highly selective hydrolysis of kinins by recombinant prolylcarboxypeptidase.

Biochemical and biophysical research communications·2010

Same author

The functional importance of the N-terminal region of human prolylcarboxypeptidase.

Biochemical and biophysical research communications·2008

Same author

Effect of the dietary brominated phenol, lanasol, on chemical biotransformation enzymes in the gumboot chiton Cryptochiton stelleri (Middendorf, 1846).

Comparative biochemistry and physiology. Toxicology & pharmacology : CBP·2000

Same author

Synthesis and biological evaluation of 2-acyl analogues of paclitaxel (Taxol).

Journal of medicinal chemistry·1998

Same author

Potential metabolic bioactivation pathways involving cyclic tertiary amines and azaarenes.

Chemical research in toxicology·1997

Same journal

Microreactors for continuous processing – How close to commercial utility?

Current opinion in drug discovery & development·2010

Same journal

Synthesis of polyketide natural products and analogs as promising anticancer agents.

Current opinion in drug discovery & development·2010

Same journal

Enantioselective synthesis of substituted oxindoles and spirooxindoles with applications in drug discovery.

Current opinion in drug discovery & development·2010

Same journal

Eliminating pharmaceutical impurities: Recent advances in detection techniques.

Current opinion in drug discovery & development·2010

Same journal

Stereoselective heterocycle synthesis through oxidative carbon-hydrogen bond activation.

Current opinion in drug discovery & development·2010

Same journal

Catalysis in aqueous media for the synthesis of drug-like molecules.

Current opinion in drug discovery & development·2010

See all related articles

Search research articles

Related Experiment Video

Updated: Jun 21, 2026

Application of Genetically Encoded Fluorescent Nitric Oxide (NO•) Probes, the geNOps, for Real-time Imaging of NO• Signals in Single Cells

Application of Genetically Encoded Fluorescent Nitric Oxide (NO•) Probes, the geNOps, for Real-time Imaging of NO• Signals in Single Cells

Published on: March 16, 2017

Inhibition on inducible nitric oxide synthase.

J M Rimoldi¹, S S Chimote

¹Department of Medicinal Chemistr, University of Mississippi, MS 38677, USA. jrimoldi@cotton.vislab.olemiss.edu

Current Opinion in Drug Discovery & Development

|August 4, 2009

Summary

This summary is machine-generated.

Nitric oxide synthase (NOS) inhibitors are crucial for managing diseases linked to excessive nitric oxide (NO) production. This review focuses on novel inhibitors targeting inducible NOS (iNOS) to control NO overproduction in various inflammatory conditions.

More Related Videos

En Face Detection of Nitric Oxide and Superoxide in Endothelial Layer of Intact Arteries

En Face Detection of Nitric Oxide and Superoxide in Endothelial Layer of Intact Arteries

Published on: February 25, 2016

Preparation of Rat Skeletal Muscle Homogenates for Nitrate and Nitrite Measurements

Preparation of Rat Skeletal Muscle Homogenates for Nitrate and Nitrite Measurements

Published on: July 29, 2021

Related Experiment Videos

Last Updated: Jun 21, 2026

Application of Genetically Encoded Fluorescent Nitric Oxide (NO•) Probes, the geNOps, for Real-time Imaging of NO• Signals in Single Cells

Application of Genetically Encoded Fluorescent Nitric Oxide (NO•) Probes, the geNOps, for Real-time Imaging of NO• Signals in Single Cells

Published on: March 16, 2017

En Face Detection of Nitric Oxide and Superoxide in Endothelial Layer of Intact Arteries

En Face Detection of Nitric Oxide and Superoxide in Endothelial Layer of Intact Arteries

Published on: February 25, 2016

Preparation of Rat Skeletal Muscle Homogenates for Nitrate and Nitrite Measurements

Preparation of Rat Skeletal Muscle Homogenates for Nitrate and Nitrite Measurements

Published on: July 29, 2021

Area of Science:

Biochemistry
Pharmacology
Immunology

Background:

Nitric oxide (NO) plays a vital role in numerous physiological and pathophysiological processes.
The inducible form of nitric oxide synthase (iNOS) is implicated in various diseases, including inflammatory conditions and shock.
Uncontrolled NO overproduction by iNOS presents a significant therapeutic challenge.

Purpose of the Study:

To review recent advancements in the identification and development of novel inhibitors targeting inducible nitric oxide synthase (iNOS).
To explore therapeutic strategies for controlling excessive NO production in disease states.

Main Methods:

Literature review of recent scientific publications on iNOS inhibitors.
Analysis of therapeutic intervention strategies for modulating NO production.
Focus on L-arginine competitive antagonists and irreversible enzyme inhibitors of iNOS.

Main Results:

The exponential growth in NO-related research highlights its complex roles.
Various strategies exist to control iNOS activity, from preventing mRNA expression to inhibiting NO action.
Novel inhibitors are being developed to specifically target iNOS.

Conclusions:

Controlling iNOS-mediated NO overproduction is critical for treating associated diseases.
Development of novel iNOS inhibitors represents a promising therapeutic avenue.
Further research into iNOS inhibition is warranted for effective disease management.